Global Fetal Monitoring, Diagnostics and Predictive Tests Market Research Report 2022-2027 Featuring Abbott Laboratories, Abcam, Ansh Labs, Beckman Coulter, Contect Medical Systems, and Dragerwerk

DUBLIN, May 3, 2023 /PRNewswire/ -- The "Fetal Monitoring, Diagnostics and Predictive Tests" report has been added to  ResearchAndMarkets.com's offering.

This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.

Worldwide, there is an increase of high-risk pregnancies that has necessitated the applications of high-level fetal and maternal monitoring during pregnancies. Healthcare vendors are constantly developing and offering new technologies to meet the challenges posed by complicated pregnancies. In most developed countries, multiple births account for about 2%-4% of all live births. Though the number of multiple births has been stabilizing in recent years, in the U.S., for every 100,000 live births, 162 births have been reported to be triplets.

Pregnancies have become complicated due to changes in lifestyles of women, conception after age 35 or as a teenager, obesity and diabetes in childbearing age and the success of assisted-reproduction.

Physical and emotional disorders that have an impact on the health of the pregnant or postpartum individual, their baby, or both are examples of pregnancy complications. Complication-causing physical and psychological disorders can develop before, during, or after pregnancy. To reduce the risk of pregnancy difficulties, it is crucial for anybody who may become pregnant to receive medical attention before, throughout, and after pregnancy. Some of the common complications associated with pregnancies are:

An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues.

This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World). For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.

Report Includes

• Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
• Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
• A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
• Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
• Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA

Chapter 9 Company Profiles

• Abbott Laboratories
• Abcam plc
• Ambisea Technology Corp. Ltd.
• Ansh Labs LLC
• Atom Medical Corp.
• Aviva Systems Biology LLC
• Beckman Coulter Inc.
• Berry Genomics
• Bionet America Inc.
• Bistos Co. Ltd.
• Contec Medical Systems Co. Ltd.
• Coopersurgical Inc.
• Creative Diagnostics
• Diagnostic Automation/Cortez Diagnostics Inc.
• Demeditec Diagnostics GmbH
• Dragerwerk AG & Co.
• Dre Inc.
• Drg International Inc.
• Eagle Biosciences Inc.
• Edan Instruments Inc.
• Esaote Spa
• Fukuda Denshi Co. Ltd.
• Ge Healthcare Ltd.
• General Meditech Inc.
• Hitachi Medical Systems America Inc.
• Hologic Inc.
• Huntleigh Healthcare LLC
• Illumina Inc.
• Infinium Medical Inc.
• Institute of Isotopes Co. Ltd.
• Leinco Technologies Inc.
• Lifewave Biomedical Inc.
• Lutech Industries Inc.
• M&B Electronic Instruments Co. Ltd.
• Medgyn Products Inc.
• Mediana Co. Ltd.
• Medical Econet GmbH
• Medichecks Ltd.
• Mindchild Medical Inc.
• Mindray Medical International Ltd.
• Monobind Inc.
• Myriad Genetics Inc.
• Natera Inc.
• Natus Medical Inc.
• Nemo Healthcare Bv
• Neoventa Medical Ab
• Nihon Kohden Corp.
• Nonin Medical Inc.
• Ob Tools Ltd.
• Penlon Ltd.
• Perkinelmer Life and Analytical Sciences Inc.
• Phoenix Pharmaceuticals Inc.
• Premaitha Health Ltd.
• Quest Diagnostics Inc.
• Ravgen
• Raybiotech Inc.
• Respironics Inc. (Philips)
• Sequenom Inc.
• Shenzhen Aeon Technology Co. Ltd.
• Shenzhen Comen Medical Instruments Co. Ltd.
• Shenzhen Jumper Medical Equipment Co. Ltd.
• Siemens Healthcare
• Sinohero Biomedical Electronics Co. Ltd.
• Smiths Medical Inc.
• Spacelabs Healthcare Inc.
• Toshiba America Medical Systems Inc.
• Uscn Life Sciences Inc.
• Ultrasound Technologies Ltd.
• United Bioresearch Inc.
• Utah Medical Products Inc.
• Vcomin Technology Ltd.
• Welch Allyn Inc.

Key Topics Covered:

Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 What's New in this Update?
1.3 Scope of Report
1.4 Methodology and Information Sources
1.5 Geographic Breakdown
1.6 Analyst's Credentials
1.7 Custom Research
1.8 Related Research Reports

Chapter 2 Summary and Highlights
2.1 Overview

Chapter 3 Market and Technology Background
3.1 High-Risk Pregnancies
3.1.1 Advanced Maternal Age (Ama)
3.1.2 Medical Conditions Existing Before Pregnancy
3.1.3 Medical Conditions Occurring During Pregnancy
3.1.4 Pregnancy-Related Issues
3.2 Fetal Growth Restrictions
3.3 Preterm Births
3.3.1 Global Epidemiology of Preterm Births
3.3.2 Classification of Preterm Birth
3.3.3 Preterm Birth Complications
3.3.4 Causes of Preterm Birth
3.3.5 Global Rates of Preterm Births
3.4 Oligohydramnios
3.5 Abnormal Placental Blood Flow
3.6 Meconium-Stained Liquor
3.6.1 Management of Msaf
3.7 Breech Presentation
3.7.1 Fetal Heart Rate (Fhr)
3.7.2 Fetal Movement
3.7.3 Maternal Contraction
3.8 Vendors and Products for Fetal Monitoring
3.8.1 Fetoscope
3.8.2 Fetal Heart Doppler
3.8.3 Fetal Monitors
3.8.4 Fetal Scalp Electrodes
3.8.5 Telemetry
3.8.6 Fetal Pulse Oximeter
3.8.7 Fetal Ultrasound
3.8.8 Neonatal Monitoring

Chapter 4 Emerging/Upcoming Technologies in the Market
4.1 Technological Advancements in Fetal Monitoring
4.1.1 Changes in Birth Technology
4.1.2 Future of Fetal Monitoring
4.1.3 New Fetal Heart Monitoring Technologies

Chapter 5 Regulatory Structure
5.1 Regulatory Framework
5.1.1 United States
5.1.2 European Union (Eu)
5.1.3 Japan

Chapter 6 Market Breakdown by Application
6.1 Market Analysis
6.2 Market Overview
6.3 Fetal Monitoring
6.3.1 Electronic Fetal Monitors
6.3.2 Fetal Dopplers
6.3.3 Other Types of Fetal Monitors
6.4 Prenatal Diagnostics
6.4.1 Fetal Ultrasound
6.4.2 Fetal Mri
6.4.3 Amniocentesis and Chorionic Villus Sampling (Cvs)
6.4.4 Noninvasive Cfdna Tests
6.4.5 Preimplantation Genetic Diagnosis and Screening (Pgd/Pgs)
6.4.6 Other Types of Prenatal Diagnostics (Maternal Serum Screening)
6.5 Neonatal Monitoring Products
6.5.1 Essentials of Prenatal Diagnosis and Fetal Therapy
6.5.2 Prenatal Screening Tests
6.5.3 Pregnancy and Prenatal Screening Tests
6.5.4 Second Trimester Maternal Hexosaminidase Screening Test
6.5.5 Radiological Studies in Prenatal Diagnosis
6.5.6 Magnetic Resonance Imaging in Fetal Diagnosis
6.5.7 Fetal Management
6.5.8 Recent Trends Prenatal Diagnostic Tests
6.5.9 Predictive Tests Related to Pregnancy
6.5.10 Effects of Chromosomal Defects on Fetuses
6.5.11 Total Number of Predictable Carrier Genetic Diseases
6.5.12 Chance of Being a Carrier of Genetic Disease
6.5.13 Causes of Birth Defects
6.5.14 Commercially Available Genetic Tests for Carrier Screening
6.5.15 Preimplantation Genetic Testing
6.5.16 Preimplantation Genetic Diagnosis (Pgd/Pgs) Technologies
6.5.17 Future of Pgd

Chapter 7 Impact of Covid-19 on the Market
7.1 Overview
7.1.1 Impact of Covid-19 on Fetal Monitoring, Diagnostics and Predictive Tests
7.1.2 Trade Restrictions and Supply Disruptions

Chapter 8 Competitive Landscape
8.1 Overview
8.2 Global Company Ranking
8.2.1 Other Key Players
8.3 Fetal Monitoring Industry Participants
8.3.1 Need for Innovations
8.3.2 Smart Fabric Belly Band
8.3.3 Laborview Sensor System
8.3.4 Bellabeat Interactive Monitoring Device
8.3.5 Benchtop Semiconductor Sequencing Procedure
8.3.6 Smart Sock Monitor

For more information about this report visit https://www.researchandmarkets.com/r/8tplbc

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets